One view of stem cell tourism comes from studies by Paul Knoepfler of the University of California, who found that most clinical trials occur in Europe and especially the United States, where regulation is strictest, but the so-called 'therapeutic' clinic locations are mostly in China, Mexico and Costa Rica, Charo says.